Skip to content

13F-HR filed by Tamarack Capital Management, LLC

Tamarack Capital Management, LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-11, with 39 holding rows worth $659,287,000.

Accession
0001095449-15-000029
Filed
2015-02-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 41 entries on the cover page, a total value of $659,287,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $659,290,000 with VALUE read as thousands by filing date, 13F file number 028-15086. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS600,000$123,324,000thousands by filing dateput
ENDOLOGIX INC29266S106COM3,960,000$60,548,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock580,000$38,895,000thousands by filing date
SPECTRANETICS CORP84760C107COM1,025,000$35,445,000thousands by filing date
iShares Russell 2000 ETF464287655SHS250,000$29,905,000thousands by filing datecall
GREATBATCH INC39153L106COM519,000$25,587,000thousands by filing date
MEDTRONIC INC585055106COM325,000$23,465,000thousands by filing date
BECTON DICKINSON & CO075887109COM165,000$22,961,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR385,000$22,141,000thousands by filing date
INOGEN INC45780L104COM674,000$21,143,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK1,100,000$19,723,000thousands by filing date
DEXCOM INC COM252131107Stock340,000$18,717,000thousands by filing date
ALKERMES PLCG01767105SHS300,000$17,568,000thousands by filing date
VERADIGM INC01988P108COMMON STOCK1,250,000$15,963,000thousands by filing date
PATTERSON COS INC703395103COM300,000$14,430,000thousands by filing date
Pfizer Inc.717081103COM450,000$14,018,000thousands by filing datecall
ATRICURE INC04963C209COM685,000$13,673,000thousands by filing date
BIO RAD LABS INC090572207CL A105,000$12,659,000thousands by filing date
Philip Morris International Inc.718172109COM150,000$12,218,000thousands by filing dateput
PERRIGO CO PLC SHSG97822103Stock70,000$11,701,000thousands by filing date
RTI BIOLOGICS INC74975N105COM2,017,241$10,490,000thousands by filing date
CATAMARAN CORP148887102COM200,000$10,350,000thousands by filing date
MYRIAD GENETICS INC62855J104COM300,000$10,218,000thousands by filing date
HANGER INC41043F208COMMON STOCK454,501$9,954,000thousands by filing date
LUMINEX CORP55027E102COMMON STOCK500,000$9,380,000thousands by filing date
NATUS MEDICAL INC639050103COM223,236$8,045,000thousands by filing date
MIMEDX GROUP INC602496101COM650,000$7,495,000thousands by filing date
MIMEDX GROUP INC602496101COM575,300$6,633,000thousands by filing datecall
STREAMLINE HEALTH SOLUTIONS86323X106COM1,138,000$4,928,000thousands by filing date
IMPRIVATA INC45323J103Cmn377,924$4,913,000thousands by filing date
CAREFUSION CORP14170T101COM78,500$4,658,000thousands by filing date
CORIUM INTL INC21887L107COM750,100$4,576,000thousands by filing date
BIO-TECHNE CORP09073M104COM40,000$3,696,000thousands by filing date
Boston Scientific Corporation101137107COM275,000$3,644,000thousands by filing dateput
TRINITY BIOTECH PLC896438306SPON ADR NEW125,000$2,189,000thousands by filing date
DISCOVERY LABORATORIES INC N254668403COM NEW1,500,000$1,740,000thousands by filing date
ICU MED INC44930G107COM13,875$1,136,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM24,442$824,000thousands by filing date
INTERSECT ENT INC46071F103COM18,149$337,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001095449-15-000029this filing2015-02-11acceptance time not in the bulk data set